Trial intelligence / Profile preview

Oliceridine fumarate + propofol vs opioid + propofol for painless hysteroscopy

ChiCTR2500108170Phase 4Not yet recruiting

Sponsor
Guilin People's Hospital
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of oliceridine and propofol (3 arms), sponsored by Guilin People's Hospital. Primary endpoints: MOAA/S score, CRS score and 2 more. Planned start Aug 2025; status: not yet recruiting.

02

Drugs

oliceridinepropofol

Beyond the preview

Go deeper on ChiCTR2500108170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500108170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call